Worldwide Leader in Bearingless Motor Technology
> 100,000 pumps sold
With over 100,000 units sold, Levitronix® is the worldwide leader in magnetically levitated bearingless motor technology, specializing in supplying process equipment for Microelectronics, Life Science, and Industrial Applications. Our products range from pump systems, mixers, and blowers to flow sensors and viscometers.
Our patented technology permits an motor and a magnetic bearing to be combined into a single unit with products that achieve maximum reliability, long life, and the ability to process in the harshest environments.
Levitronix® has been a key participant in the Microelectronics industry for over 20 years, providing ultrapure pump systems, mixers, and flow sensors that enable chip manufacturers globally to process smallest wafer structures. Levitronix®is the market leader in several applications, including single-wafer processing, CMP slurry delivery, or plating.
In the Life Sciences market, Levitronix®supplies single- and multi-use pumps, mixers, and flow sensors that help biopharmaceutical companies globally to process shear sensitive fluids such as cell-based vaccines, biologics, and gene therapies.
Levitronix® leverages technology leadership and Swiss quality to deliver integrated solutions for improved process yield. We focus on technical customer support, advanced quality control, and long-term product availability. A firm commitment to responsible business, sustainability, and long-term partnerships underpins everything we do.
Levitronix® is located in Zurich, Switzerland, with production and RnD facilities in the USA and Asia. With offices around the world, we are present in all regions where our customers are active to effectively respond to their needs.
> 100,000 pumps sold
> 25 years experience in bearingless motor technology
Levitronix® offices around the globe
Main office in Zürich, Switzerland
> 300 patents granted
First and only company to market bearingless motors
Levitronix® was founded in 2001 as a spin-off from Sulzer, a 4B USD Swiss industrial technology company at that time. Levitronix®‘s history stretches back many years before. In the late ’80s and early ’90s, the concept of a maglev bearingless motor was developed at the Swiss Federal Institute of Technology (ETH) and then commercialized with Sulzer and other industrial partners in the late ’90s.
First FDA approved maglev blood pump
Levitronix® was the first company to receive CE and FDA approval for a maglev blood pump. The medical device is used for temporary extracorporeal mechanical circulatory support and ensures excellent hemocompatibility. Levitronix®‘s heart assist business was sold to Thoratec Corporation in 2011.
From Switzerland (to) all
over the world
Levitronix® vouches for Swiss quality, which is why research, development, and the main manufacturing facility are in Zurich, Switzerland. Though Switzerland is our home, we always want to be where our customers are, so we may continuously provide them with a prompt and professional service. Levitronix® has established subsidiaries around the globe that act as representative offices such as in the USA (4x), Taiwan (1x), Japan (3x), and Korea (1x).
Market leader in Pumps for Semiconductor
Levitronix® has been a key supplier to the Semiconductor industry since the start of the company. Compared to other pump systems, the bearingless pump principle allows the user to process ultrapure fluids with virtually no contamination. Soon after the market entry, Levitronix® became the standard in various processes such as cleaning, plating or CMP slurry delivery.
Rather than just pumps, Levitronix® provides solutions to improve process yield. That’s why leading companies in the industry trust Levitronix® and share their success stories.
Ultrasonic Flow Sensors
The integrated controllers of Levitronix® pump systems allow for control of process parameters such as flow. To provide complete, highest purity solutions to customers, Levitronix® released the LEVIFLOW® ultrasonic flow sensors in 2009. With the entry into the Life Science industry in 2014, the product line was expanded by single-use inline and reusable clamp-on sensors.
Introduction of PuraLev®
In 2014, Levitronix® released the PuraLev®single-use and multi-use pumps for biopharmaceutical production. Compared to peristaltic or piston-diaphragm pumps, the bearingless pump principle allows processing shear-sensitive fluids extremely gently, resulting in improved product yield. Levitronix® quickly becomes the industry standard in pumps for bioreactor perfusion, a process that requires lowest impact on cell viability.
Three generations of bearingless
Since its inception, Levitronix® has released three generations of maglev pump systems. The first generation was released between 2001 and 2008 and consisted of 3 maglev motor sizes and close to 30 pump heads to cover the most frequent applications. The second generation (released between 2008 and 2018) was characterized by improved performance and value, and an enormous variety of pump heads and controller variations to fit our customer’s requirements as close as possible. The third generation of pumps (released from 2018) is designed for ease of use and comes with an integrated controller and substantially reduced footprint. We understand the need for the long-term availability of process equipment. That’s why two decades after product release, Levitronix® pump systems of the first generation are still available.
Bearingless fans, mixers and more
The application of Levitronix®‘s bearingless motor technology is not limited to pumps. Over the course of the company’s history, various other maglev products were released, including mixers, wafer rotation systems, fans, and viscometers. All products are designed for highest purity, gentle processing, reliability, and a long lifetime.
New headquarter, research center, and production facility in Zurich, Switzerland
Since its inception, Levitronix® had been steadily growing and expanding its facilities. To position the company for future growth, Levitronix® relocated its headquarters and main production facility to a new building that offers 75,000 sqft of floor space in the spring of 2022.